Solution structure of the HIV-1 integrase-binding domain in LEDGF/p75
The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Lens epithelium-derived growth factor (LEDGF)/p75 is the dominant binding partner of HIV-1 integrase (IN) in human cells. We have determined the NMR structure of the integrase-binding domain (IBD) in LEDGF and identified amino acid residues essential for the interaction. The IBD is a compact right-handed bundle composed of five alpha-helices. Based on folding topology, the IBD is structurally related to a diverse family of alpha-helical proteins that includes eukaryotic translation initiation factor eIF4G and karyopherin-beta. LEDGF residues essential for the interaction with IN were localized to interhelical loop regions of the bundle structure. Interaction-defective IN mutants were previously shown to cripple replication although they retained catalytic function. The initial structure determination of a host cell factor that tightly binds to a retroviral enzyme lays the groundwork for understanding enzyme-host interactions important for viral replication.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The LEDGF/p75 IBD is an α-helical domain topologically related to HEAT repeat proteins108.”
From Structure and function of retroviral integrase (2022) · cites this paper as [108]
Citations
Cites
MOLMOL: A program for display and analysis of macromolecular structures
Koradi, R., Billeter, M., & Wüthrich, K. (1996) · Journal of Molecular Graphics · doi:10.1016/0263-7855(96)00009-4 · Cited by 7,163
AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR
Laskowski, R., Rullmann, J. A., MacArthur, M., Kaptein, R., & Thornton, J. (1996) · Journal of Biomolecular NMR · doi:10.1007/bf00228148 · Cited by 5,502
LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M. P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C. S., Pawliuk, R., Morillon, E., et al. (2003) · Science · doi:10.1126/science.1088547 · Cited by 3,587
X-PLOR Version 3.1: A System for X-ray Crystallography and NMR
Brünger, A. T. (1992) · Medical Entomology and Zoology · Cited by 3,424
Protein backbone angle restraints from searching a database for chemical shift and sequence homology
Cornilescu, G., Delaglio, F., & Bax, A. (1999) · Journal of Biomolecular NMR · doi:10.1023/a:1008392405740 · Cited by 2,957 · cited 1×
“Torsion angles p and ψ were predicted from 1 Hα, 13 Cα, 13 Cβ, C′ and backbone 15 N chemical shifts using TALO”
MethodAnatomy of hot spots in protein interfaces
Bogan, A. A., & Thorn, K. S. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1843 · Cited by 1,988
HIV-1 Integrase Forms Stable Tetramers and Associates with LEDGF/p75 Protein in Human Cells
Cherepanov, P., Maertens, G., Proost, P., Devreese, B., Van Beeumen, J., Engelborghs, Y., De Clercq, E., & Debyser, Z. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209278200 · Cited by 704 · cited 1×
“dtd" [ ]> Transcriptional coactivator p75, more commonly known as LEDGF, is a chromatin-associated protei”
Self-citationComparison of ARM and HEAT protein repeats
Andrade, M. A., Petosa, C., O’Donoghue, S. I., Müller, C. W., & Bork, P. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4624 · Cited by 512
LEDGF/p75 Is Essential for Nuclear and Chromosomal Targeting of HIV-1 Integrase in Human Cells
Maertens, G., Cherepanov, P., Pluymers, W., Busschots, K., De Clercq, E., Debyser, Z., & Engelborghs, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303594200 · Cited by 493 · cited 2×
“The t(9;11)(p22;p15) chromosomal translocation associated with acute myeloid leukemia results in the fusion of the nucleoporin NUP98 to LEDGF5.”
BackgroundSelf-citationStructure of the nuclear transport complex karyopherin-β2–Ran˙GppNHp
Chook, Y. M., & Blobel, G. (1999) · Nature · doi:10.1038/20375 · Cited by 342
Cited by
An essential role for LEDGF/p75 in HIV integration
Llano, M., Saenz, D. T., Meehan, A., Wongthida, P., Peretz, M., Walker, W. H., Teo, W., & Poeschla, E. M. (2006) · Science · doi:10.1126/science.1132319 · Cited by 537
Shun, M.-C., Raghavendra, N. K., Vandegraaff, N., Daigle, J. E., Hughes, S., Kellam, P., Cherepanov, P., & Engelman, A. (2007) · Genes & Development · doi:10.1101/gad.1565107 · Cited by 467
Self-citationThe structural biology of HIV-1: mechanistic and therapeutic insights
Engelman, A., & Cherepanov, P. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2747 · Cited by 424
“The IN-binding domain of LEDGF is a pseudo HEAT analogous topology (PHAT) domain that consists of two units of a helix–hairpin–helix repea”
BackgroundSelf-citationStructural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75
Cherepanov, P., Ambrosio, A. L. B., Rahman, S., Ellenberger, T., & Engelman, A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506924102 · Cited by 408
Self-citationRole of PSIP1/LEDGF/p75 in Lentiviral Infectivity and Integration Targeting
Marshall, H. M., Ronen, K., Berry, C., Llano, M., Sutherland, H., Saenz, D., Bickmore, W., Poeschla, E., & Bushman, F. D. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001340 · Cited by 241
“The crystal structure of the catalytic domain of HIV IN (residues 50–212) bound to the integrase binding domain (IBD) was solved, which showed that a pair of LEDGF/p75-IBD molecules could bind at symmetry-related positions at the interface of the IN catalytic domain dimer [33, 34 ]”
Lesbats, P., Engelman, A. N., & Cherepanov, P. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00125 · Cited by 233
Self-citationThe lentiviral integrase binding protein LEDGF/p75 and HIV-1 replication
Engelman, A., & Cherepanov, P. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000046 · Cited by 231
“interaction in vitro, defining these amino acids as hotspot contact residues [51].”
BackgroundInfluentialSelf-citationVandekerckhove, L., Christ, F., Van Maele, B., De Rijck, J., Gijsbers, R., Van den Haute, C., Witvrouw, M., & Debyser, Z. (2006) · Journal of Virology · doi:10.1128/jvi.80.4.1886-1896.2006 · Cited by 208
“The integrase binding domain is located between amino acids 347 and 429, as described previously (8, 13, 40).”
MethodLEDGF (p75) promotes DNA-end resection and homologous recombination
Daugaard, M., Baude, A., Fugger, K., Povlsen, L. K., Beck, H., Sørensen, C. S., Petersen, N. H. T., Sorensen, P. H. B., Lukas, C., Bartek, J., et al. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2314 · Cited by 206
Llano, M., Vanegas, M., Hutchins, N., Thompson, D., Delgado, S., & Poeschla, E. M. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.04.073 · Cited by 199
Cellular co-factors of HIV-1 integration
Van Maele, B., Busschots, K., Vandekerckhove, L., Christ, F., & Debyser, Z. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.12.002 · Cited by 185
Turlure, F. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl052 · Cited by 181
“Residues 412–428 form the C-terminal a helix of the pseudo HEAT repeat analogous topology (PHAT) IBD both in solution (25) and as part of a co-crystallized complex with HIV-1 integrase (35).”
BackgroundInfluentialCherepanov, P. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl885 · Cited by 173
“Wild type and D366N LEDGF were made as previously described (24,25,31).”
BackgroundMethodResultInfluentialSelf-citationNew Class of HIV-1 Integrase (IN) Inhibitors with a Dual Mode of Action
Tsiang, M., Jones, G. S., Niedziela-Majka, A., Kan, E., Lansdon, E. B., Huang, W., Hung, M., Samuel, D., Novikov, N., Xu, Y., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.347534 · Cited by 167
Hare, S., Shun, M.-C., Gupta, S. S., Valkov, E., Engelman, A., & Cherepanov, P. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000259 · Cited by 166
“Conversely, the complementary basic residues are conserved among all known LEDGF and HRP2 orthologs, with some variation only at the position corresponding to LEDGF Arg-405, where Arg or Lys is accommodated [22,24,33,34].”
BackgroundMethodResultInfluentialSelf-citationDe Rijck, J., Vandekerckhove, L., Gijsbers, R., Hombrouck, A., Hendrix, J., Vercammen, J., Engelborghs, Y., Christ, F., & Debyser, Z. (2006) · Journal of Virology · doi:10.1128/jvi.00801-06 · Cited by 164
“The D366A mutation renders the IBD defective for interaction with HIV-1 integrase (7).”
BackgroundInfluentialNuclear landscape of HIV-1 infection and integration
Lušić, M., & Siliciano, R. F. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.162 · Cited by 201
Novel approaches to inhibiting HIV-1 replication
Adamson, C. S., & Freed, E. O. (2010) · Antiviral Research · doi:10.1016/j.antiviral.2009.09.009 · Cited by 144
“IN is known to form multimers (dimers and tetramers) and an interhelical loop in the LEDGF/p75 IBD fits into a cleft formed by the dimer interface of IN (Cherepanov et al., 2005).”
BackgroundCharacterization and structural analysis of HIV-1 integrase conservation.
Ceccherini‐Silberstein, F., Malet, I., D’Arrigo, R., Antinori, A., Marcelin, A., & Perno, C. F. (2009) · PubMed · Cited by 165
Identification of the LEDGF/p75 Binding Site in HIV-1 Integrase
Busschots, K., Voet, A. R. D., Maeyer, M. D., Rain, J., Emiliani, S., Bénarous, R., Desender, L., Debyser, Z., & Christ, F. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.10.094 · Cited by 161
Chromatin organization at the nuclear pore favours HIV replication
Lelek, M., Casartelli, N., Pellin, D., Rizzi, E., Souque, P., Severgnini, M., Di Serio, C., Fricke, T., Diaz-Griffero, F., Zimmer, C., et al. (2015) · Nature Communications · doi:10.1038/ncomms7483 · Cited by 136
Molecular mechanisms of retroviral integration site selection
Kvaratskhelia, M., Sharma, A., Larue, R. C., Serrao, E., & Engelman, A. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku769 · Cited by 135
“A short interhelical loop from the IBD docks into a narrow, Vshaped cavity at the interface of two IN CCD molecules and establishes functionally critical hydrogen bonds between LEDGF/p75 hotspot residue Asp366 and the backbone amides of IN residues Glu170 and His171 (Figure 2B and C) (108,110).”
BackgroundSelf-citationDiscovery of structurally diverse HIV-1 integrase inhibitors based on a chalcone pharmacophore
Deng, J. N., Sanchez, T. W., Al‐Mawsawi, L. Q., Dayam, R., Yunes, R. A., Garofalo, A., Bolger, M. B., & Neamati, N. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.04.041 · Cited by 132
Structure and function of retroviral integrase
Maertens, G. N., Engelman, A. N., & Cherepanov, P. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00586-9 · Cited by 124
Self-citationMcKee, C. J., Kessl, J. J., Shkriabai, N., Dar, M. J., Engelman, A., & Kvaratskhelia, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805843200 · Cited by 129
Self-citationIntegrase, LEDGF/p75 and HIV replication
Poeschla, E. M. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7540-5 · Cited by 165
Transcriptional co-activator p75 binds and tethers the Myc-interacting protein JPO2 to chromatin
Maertens, G. N., Cherepanov, P., & Engelman, A. (2006) · Journal of Cell Science · doi:10.1242/jcs.02995 · Cited by 125
“The interhelical loop regions of the IBD can probably bind to divergent lentiviral INs by recognizing the backbone conformation of the viral proteins (Cherepanov et al., 2005a).”
BackgroundMethodInfluentialSelf-citationVirus Evolution Reveals an Exclusive Role for LEDGF/p75 in Chromosomal Tethering of HIV
Hombrouck, A., De Rijck, J., Hendrix, J., Vandekerckhove, L., Voet, A., Maeyer, M. D., Witvrouw, M., Engelborghs, Y., Christ, F., Gijsbers, R., et al. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030047 · Cited by 125
“The control cells overexpress the D366A mutant of eGFP-D325 known to be defective for interaction with HIV-1 IN [20].”
BackgroundStructural Basis for Functional Tetramerization of Lentiviral Integrase
Hare, S., Di Nunzio, F., Labeja, A., Wang, J., Engelman, A., & Cherepanov, P. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000515 · Cited by 122
“To remove the disordered C-terminal tail (residues 436–471) [60], the protein was digested with HRV14 3C protease (20 mg protease per mg protein) at 7uC in the presence of 10 mM DTT.”
MethodSelf-citationRetroviral DNA integration: HIV and the role of LEDGF/p75
Ciuffi, A., & Bushman, F. D. (2006) · Trends in Genetics · doi:10.1016/j.tig.2006.05.006 · Cited by 152
“The crystal structure of the catalytic domain of HIV IN (residues 50–212) in a complex with IBD has been solved; it revealed a pair of LEDGF-IBD molecules bound at symmetryrelated positions at the interface of the IN dimer [67, 68 ].”
BackgroundMicroRNAs and HIV-1 Infection: Antiviral Activities and Beyond
Swaminathan, G., Navas, S., & Martín‐García, J. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.12.017 · Cited by 125
Vranckx, L. S., Demeulemeester, J., Saleh, S., Boll, A., Vansant, G., Schrijvers, R., Weydert, C., Battivelli, E., Verdin, E., Cereseto, A., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.04.039 · Cited by 113
Structural biology of retroviral DNA integration
Li, X., Krishnan, L., Cherepanov, P., & Engelman, A. (2011) · Virology · doi:10.1016/j.virol.2010.12.008 · Cited by 112
“…mimicked that of LEDGF (P. Cherepanov and A. Engelman, unpublished observations; Busschots et al., 2005), the host factor has become a valuable lentiviral IN structural biology tool (Cherepanov et al., 2005a; Gupta et al., 2010; Hare et al., 2009a; Hare et al., 2009b; Michel et al., 2009).”
BackgroundMethodInfluentialSelf-citationThe LEDGF/p75 integrase interaction, a novel target for anti-HIV therapy
Christ, F., & Debyser, Z. (2012) · Virology · doi:10.1016/j.virol.2012.09.033 · Cited by 131
Vandegraaff, N., Devroe, E., Turlure, F., Silver, P. A., & Engelman, A. (2006) · Virology · doi:10.1016/j.virol.2005.11.022 · Cited by 106
“LEDGF/p75 residue Asp-366 is essential for the interaction with IN, and full-length LEDGF/ p75 containing the D366N amino acid substitution displayed approximately 8% of wild-type LEDGF/p75 activity in the IN stimulation assay (Cherepanov et al., 2005; data not shown).”
BackgroundMethodInfluentialSelf-citationOchs, R., Mähler, M., Basu, A., Ríos-Colón, L., Sanchez, T. W., Andrade, L. E. C., Fritzler, M. J., & Casiano, C. A. (2015) · Clinical and Experimental Medicine · doi:10.1007/s10238-015-0367-0 · Cited by 105
“Interactors of the IBD in addition to HIV-IN include the pogo transposable element PogZ, the c-Myc interacting protein JPO2, the Cdc7-activator of S-phase kinase (ASK), and the leukemiaassociated transcription complex Menin-MLL (mixed lineage leukemia) [52–56, 83].”
BackgroundInfluentialInhibiting the HIV Integration Process: Past, Present, and the Future
Santo, R. D. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400674a · Cited by 112
Lens Epithelium-derived Growth Factor/p75 Interacts with the Transposase-derived DDE Domain of PogZ
Bartholomeeusen, K., Christ, F., Hendrix, J., Rain, J.-C., Emiliani, S., Benarous, R., Debyser, Z., Gijsbers, R., & De Rijck, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807781200 · Cited by 99
Wang, H., Jurado, K. A., Wu, X., Shun, M.-C., Li, X., Ferris, A. L., Smith, S. J., Patel, P. A., Fuchs, J. R., Cherepanov, P., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks913 · Cited by 100
“3% similar considering conservative substitutions (38) (Supplementary Figure S1A).”
BackgroundSelf-citationPreclinical Profile of BI 224436, a Novel HIV-1 Non-Catalytic-Site Integrase Inhibitor
Fenwick, C., Amad, M., Bailey, M. D., Bethell, R., Bös, M., Bonneau, P., Cordingley, M., Coulombe, R., Duan, J., Edwards, P., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02719-13 · Cited by 99
“Concomitant with these studies, this pocket also was shown to serve as the binding site for LEGDF (20).”
BackgroundRetroviral Integrase Proteins and HIV-1 DNA Integration
Krishnan, L., & Engelman, A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.397760 · Cited by 97
“The LEDGF/p75 IBD is a PHAT (pseudo-HEAT repeat analogous topology) domain composed of two copies of a helixhairpin-helix HEAT (huntingtin/elongation factor 3/subunit A of protein phosphatase 2A/yeast PI3K Tor1) repeat (94) and Ile-365 and Asp-366 at the tip of the N-terminal hairpin nestle into a cleft at the IN CCD-…”
BackgroundSelf-citationRetroviral Integrase Structure and DNA Recombination Mechanism
Engelman, A., & Cherepanov, P. (2014) · Microbiology Spectrum · doi:10.1128/microbiolspec.mdna3-0024-2014 · Cited by 94
“The LEDGF/p75 IBD is a compact alpha helical domain, with the hairpins from two helix-hairpin-helix folds situated on one end of the elongated structure (154).”
BackgroundSelf-citationHost proteins involved in HIV infection: New therapeutic targets
Arhel, N. J., & Kirchhoff, F. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.12.003 · Cited by 118
Cellular and molecular mechanisms of HIV-1 integration targeting
Engelman, A., & Singh, P. K. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2772-5 · Cited by 113
“1 3 domain (for pseudo HEAT repeat analogous topology) composed of two helix–hairpin–helix motifs, and evolutionarily conserved hotspot residues Ile365 and Asp366 in the N-terminal hairpin were critical for integrase binding [101].”
BackgroundSelf-citationDifferential Interaction of HIV-1 Integrase and JPO2 with the C Terminus of LEDGF/p75
Bartholomeeusen, K., Rijck, J. D., Busschots, K., Desender, L., Gijsbers, R., Emiliani, S., Bénarous, R., Debyser, Z., & Christ, F. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.06.090 · Cited by 100
Crowe, B. L., Larue, R. C., Yuan, C., Hess, S., Kvaratskhelia, M., & Foster, M. P. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1516813113 · Cited by 83
“In the case of lentiviruses and LEDGF/ p75, a short interhelical loop of the integrase binding domain (IBD) of LEDGF/p75 engages a cavity on the dimer interface of two HIV-1 catalytic core domains (35, 36).”
BackgroundLEDGINs, non-catalytic site inhibitors of HIV-1 integrase: a patent review (2006 – 2014)
Demeulemeester, J., Chaltin, P., Marchand, A., De Maeyer, M., Debyser, Z., & Christ, F. (2014) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2014.898753 · Cited by 83
“Finally, solution of the LEDGF/ p75 IBD--HIV-1 IN CCD co-crystal structure [31,46] plus the observation that IBD-derived peptides also modulate IN oligomerization and block IN catalytic activity [47] further spurred on research efforts to develop a small molecule inhibitor of the IN -- LEDGF/p75 interaction [48-53].”
BackgroundArchitecture and RNA binding of the human negative elongation factor
Vos, S. M., Pöllmann, D., Caizzi, L., Hofmann, K. B., Rombaut, P., Zimniak, T., Herzog, F., & Cramer, P. (2016) · eLife · doi:10.7554/elife.14981 · Cited by 83
“that resembles (Holm and Rosenstrom, 2010) the fold of the HIV integrase-binding domain present in human PC4 and SFRS1-interacting protein (PSIP1) (Cherepanov et al., 2005) (Figure 2B).”
BackgroundInfluentialAllosteric Inhibition of Human Immunodeficiency Virus Integrase
Gupta, K., Brady, T., Dyer, B. M., Malani, N., Hwang, Y., Male, F., Nolte, R. T., Wang, L., Velthuisen, E., Jeffrey, J., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.551119 · Cited by 81
“The structure of the LEDGF/p75 IBD IN(CCD) complex was determined by Cherepanov and colleagues (17, 18).”
Shun, M.-C., Botbol, Y., Li, X., Di Nunzio, F., Daigle, J. E., Yan, N., Lieberman, J., Lavigne, M., & Engelman, A. (2008) · Journal of Virology · doi:10.1128/jvi.01561-08 · Cited by 78
“Lentiviruses may very well utilize a LEDGF/p75 independent pathway to accomplish ca. 2 to 20% of their overall integrations (27, 34, 55), but we speculate that the lion’s share occurs through the PIC engaging chromatinbound LEDGF/p75 via the IBD.”
InfluentialSelf-citationHIV infection of non-dividing cells: a divisive problem
Fassati, A. (2006) · Retrovirology · doi:10.1186/1742-4690-3-74 · Cited by 80
“Is it possible to reconcile these findings with the observation that, at least in vitro, IN can be imported into the nucleus by an active mechanism in the absence of LEDGF/ p75? It is perhaps interesting that the integrase-binding domain in LEDGF/p75 is structurally closely related to the HEAT repeat found, amongst ot…”
BackgroundThe chromatin landscape at the HIV-1 provirus integration site determines viral expression
Vansant, G., Chen, H.-C., Zorita, E., Trejbalová, K., Miklík, D., Filion, G., & Debyser, Z. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa536 · Cited by 78
Multifaceted HIV integrase functionalities and therapeutic strategies for their inhibition
Engelman, A. N. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.rev119.006901 · Cited by 78
“The LEDGF/p75 IBD is a PHAT domain (for pseudo-HEAT repeat analogous topology) composed of two helixhairpin-helix HEAT repeats (182) (Fig.”
BackgroundSelf-citationHigh-resolution profiling of the LEDGF/p75 chromatin interaction in the ENCODE region
De Rijck, J., Bartholomeeusen, K., Ceulemans, H., Debyser, Z., & Gijsbers, R. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq410 · Cited by 77
“LEDGF/p75 D366A, HIV integrase interaction deficient LEDGF/ p75 (40).”
BackgroundMethodMultiple cellular proteins interact with LEDGF/p75 through a conserved unstructured consensus motif
Tesina, P., Čermáková, K., Hořejší, M., Procházková, K., Fábry, M., Sharma, S., Christ, F., Demeulemeester, J., Debyser, Z., Rijck, J. D., et al. (2015) · Nature Communications · doi:10.1038/ncomms8968 · Cited by 74
Allosteric inhibition of HIV-1 integrase activity
Engelman, A., Kessl, J. J., & Kvaratskhelia, M. (2013) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2013.04.010 · Cited by 75
Self-citationDemeulemeester, J., De Rijck, J., Gijsbers, R., & Debyser, Z. (2015) · BioEssays · doi:10.1002/bies.201500051 · Cited by 71
Al‐Mawsawi, L. Q., & Neamati, N. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.09.005 · Cited by 82
Fadel, H. J., Morrison, J. H., Saenz, D. T., Fuchs, J. R., Kvaratskhelia, M., Ekker, S. C., & Poeschla, E. M. (2014) · Journal of Virology · doi:10.1128/jvi.01397-14 · Cited by 70
What Integration Sites Tell Us about HIV Persistence
Hughes, S. H., & Coffin, J. M. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.04.010 · Cited by 80
“In both cases, the N-terminal domains bind chromatin and IN binds to the C-terminal portion (Cherepanov et al., 2005; Crowe et al., 2016).”
Du, L., Zhao, Y., Chen, J., Yang, L., Zheng, Y., Tang, Y., Shen, X., & Jiang, H. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.07.139 · Cited by 77
LEDGF/p75 Proteins with Alternative Chromatin Tethers Are Functional HIV-1 Cofactors
Meehan, A. M., Saenz, D. T., Morrison, J. H., Garcia-Rivera, J. A., Peretz, M., Llano, M., & Poeschla, E. M. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000522 · Cited by 68
“may be needed to eradicate all detectable interaction of these proteins with IN [22].”
BackgroundHughes, S. M., Jenkins, V. A., Dar, M. J., Engelman, A., & Cherepanov, P. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.036491 · Cited by 80
Self-citationA ubiquitous disordered protein interaction module orchestrates transcription elongation
Cermakova, K., Demeulemeester, J., Lux, V., Nedomova, M., Goldman, S. R., Smith, E. A., Srb, P., Hexnerova, R., Fabry, M., Madlikova, M., et al. (2021) · Science · doi:10.1126/science.abe2913 · Cited by 67
Li, W., Singh, P. K., Sowd, G. A., Bedwell, G. J., Jang, S., Achuthan, V., Oleru, A. V., Wong, D., Fadel, H. J., Lee, K., et al. (2020) · mBio · doi:10.1128/mbio.02254-20 · Cited by 64
“Functionally critical PWWP domain and IBD regions were nearly identical, including IBD hot spot residues Ile365, Asp366, and Phe406 important for the interaction with HIV-1 integrase (38) (Fig.”
Self-citationRahman, S., Lu, R., Vandegraaff, N., Cherepanov, P., & Engelman, A. (2006) · Virology · doi:10.1016/j.virol.2006.08.011 · Cited by 73
Self-citationZamborlini, A., Coiffic, A., Beauclair, G., Delelis, O., Paris, J., Koh, Y., Magne, F., Giron, M.-L., Tobaly-Tapiero, J., Deprez, E., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.189274 · Cited by 72
“Immunoprecipitation assay was performed as described (46).”
MethodInfluentialSelf-citationBotbol, Y., Raghavendra, N. K., Rahman, S., Engelman, A., & Lavigne, M. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm1127 · Cited by 63
“LEDGF/p75 mutants lacking the IBD, or containing the substitution of asparigine for Asp-366 that abrogates the interaction with integrase in vitro ( 25 ) and in yeast cells (26), fail to rescue the infection defect accrued via LEDGF/p75 depletion (15,23).”
BackgroundMethodInfluentialSelf-citationAllosteric Inhibitor Development Targeting HIV‐1 Integrase
Al‐Mawsawi, L. Q., & Neamati, N. (2011) · ChemMedChem · doi:10.1002/cmdc.201000443 · Cited by 61
Ciuffi, A., Diamond, T. L., Hwang, Y., Marshall, H. M., & Bushman, F. D. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.960 · Cited by 62
Hendrix, J., Gijsbers, R., Rijck, J. D., Voet, A. R. D., Hotta, J., McNeely, M., Hofkens, J., Debyser, Z., & Engelborghs, Y. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq933 · Cited by 65
“The ‘integrase binding domain’ (IBD) of LEDGF/p75 (amino acids 347–429) shows structural homology to known protein–protein interaction motifs (27) and has been shown to interact with multiple other proteins in cells: (i) JPO2, a Myc transcription factor interacting protein (28), (ii) the menin tumor suppressor, implic…”
BackgroundPandey, K. K., Sinha, S., & Grandgenett, D. P. (2007) · Journal of Virology · doi:10.1128/jvi.02322-06 · Cited by 58
“described (9, 10), and its concentration was determined using the molar extinction coefficient value of 16,500 M 1 cm (1), determined from its amino acid”
BackgroundMethodInfluentialPhage Display-directed Discovery of LEDGF/p75 Binding Cyclic Peptide Inhibitors of HIV Replication
Desimmie, B. A., Humbert, M., Lescrinier, E., Hendrix, J., Vets, S., Gijsbers, R., Ruprecht, R. M., Dietrich, U., Debyser, Z., & Christ, F. (2012) · Molecular Therapy · doi:10.1038/mt.2012.132 · Cited by 57
Hou, Y., McGuinness, D. E., Prongay, A. J., Feld, B., Ingravallo, P., Ogert, R. A., Lunn, C. A., & Howe, J. A. (2008) · SLAS Discovery · doi:10.1177/1087057108317060 · Cited by 56
“This enlarged version of the IBD domain was used for protein purification purposes.(18,19) The PCR products encoding LEDGF/p75 or residues 347-471 were cloned into pGEX-6P-3 (GE HealthCare, Piscataway, NJ) for expression of full-length LEDGF/p75 fusion protein or the p75 IBD fusion protein, in which glutathione S-tran…”
MethodViral Integration and Consequences on Host Gene Expression
Desfarges, S., & Ciuffi, A. (2012) · Springer eBooks · doi:10.1007/978-94-007-4899-6_7 · Cited by 80
“…the HIV-1 IN-interacting protein, LEDGF/p75, that was shown to play a key role in integration ef fi ciency as well as integration site distribution (Cherepanov et al. 2005a, b ; Ciuf fi et al. 2005 ; Engelman and Cherepanov 2008 ; Llano et al. 2006 ; Marshall et al. 2007 ; Poeschla 2008 ) ,…”
BackgroundAl‐Mawsawi, L. Q., Christ, F., Dayam, R., Debyser, Z., & Neamati, N. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.02.076 · Cited by 60
“Here, we examined the biological activity of the LEDGF/p75 derived peptide, (355)IHAEIKNSLKIDNLDVNRCIEAL(377), which contains two IN interacting residues (I365 and D366) first identified in the IN binding domain (IBD) solution structure [17].”
BackgroundČermáková, K., Tesina, P., Demeulemeester, J., El Ashkar, S., Méreau, H., Schwaller, J., Řezáčová, P., Veverka, V., & De Rijck, J. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3602 · Cited by 53
“The MLL and HIV-1 binding domains in LEDGF/p75 overlap but are not identical The structure of the LEDGF/p75 IBD in complex with the HIV-1 integrase core domain has been resolved by X-ray crystallography (26, 38).”
BackgroundMethodHuman Immunodeficiency Virus Integration Efficiency and Site Selection in Quiescent CD4 + T Cells
Vatakis, D. N., Kim, S., Kim, N., Chow, S. A., & Zack, J. A. (2009) · Journal of Virology · doi:10.1128/jvi.00356-09 · Cited by 53
“LEDGF/p75 has been shown to interact with integrase within the context of a larger complex (3, 17, 21, 22, 27, 49, 50, 62, 68).”
BackgroundPeat, T. S., Rhodes, D. I., Vandegraaff, N., Le, G., Smith, J. A., Clark, L. J., Jones, E. D., Coates, J. A. V., Thienthong, N., Newman, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040147 · Cited by 52
“making it a tantalizing target for inhibitors [11,14,18,19].”
BackgroundKessl, J. J., Li, M., Ignatov, M., Shkriabai, N., Eidahl, J. O., Feng, L., Musier-Forsyth, K., Craigie, R., & Kvaratskhelia, M. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr581 · Cited by 52
“Purified recombinant LEDGF/p75 and LEDGF/IBD were obtained as described previously (14,38,46).”
MethodMéreau, H., Rijck, J. D., Čermáková, K., Kutz, A., Juge, S., Demeulemeester, J., Gijsbers, R., Christ, F., Debyser, Z., & Schwaller, J. (2013) · Leukemia · doi:10.1038/leu.2013.10 · Cited by 55
Zhao, Z., McKee, C. J., Kessl, J. J., Santos, W. L., Daigle, J. E., Engelman, A., Verdine, G., & Kvaratskhelia, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m705241200 · Cited by 49
Self-citationYeast two-hybrid detection of integrase–host factor interactions
Rain, J., Cribier, A., Gérard, A., Emiliani, S., & Bénarous, R. (2009) · Methods · doi:10.1016/j.ymeth.2009.02.002 · Cited by 58
HIV-1 Integrase Multimerization as a Therapeutic Target
Feng, L., Larue, R. C., Slaughter, A., Kessl, J. J., & Kvaratskhelia, M. (2015) · Current Topics in Microbiology and Immunology · doi:10.1007/82_2015_439 · Cited by 45
“The X-ray structure for an archetypal ALLINI BI-1001 bound to IN CCD shows that the interactions with subunit 1 are mediated through a hydrogen bonding network between the critical pharmacophore carboxylic acid and IN residues Glu170 and His171acid as well as between the metoxy group and Thr174 side chain (Kessl et al…”
BackgroundInfluentialTsiang, M., Jones, G. S., Hung, M., Mukund, S., Han, B., Liu, X., Babaoglu, K., Lansdon, E., Chen, X., Todd, J., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.040121 · Cited by 45
Gijsbers, R., Vets, S., De Rijck, J., Ocwieja, K. E., Ronen, K., Malani, N., Bushman, F. D., & Debyser, Z. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.255711 · Cited by 44
RetractedJohnson, B. C., Métifiot, M., Pommier, Y. G., & Hughes, S. H. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05292-11 · Cited by 48
“The crystal structure of an HIV-2 IN-IBD complex shows contacts between LEDGF and both the NTD and CCD of IN (13, 15, 29).”
BackgroundInfluentialZielske, S. P., & Stevenson, M. (2006) · Journal of Virology · doi:10.1128/jvi.02470-05 · Cited by 43
“The specificity and strength of the LEDGFp75-integrase interaction as determined by crystal structure analysis suggest an important role for LEDGFp75 in HIV biology (4).”
The role of lysine 186 in HIV-1 integrase multimerization
Berthoux, L., Sebastian, S., Muesing, M. A., & Luban, J. (2007) · Virology · doi:10.1016/j.virol.2007.02.029 · Cited by 48
“…one could speculate that mutations in the 186-188 region might disrupt the structure of the nearby LEDGF-binding domain (residues 168 to 171) (Cherepanov et al., 2005a; Cherepanov et al., 2005b), thus interfering with IN nuclear transport and function (Ciuffi et al., 2005; Llano et al.,…”
BackgroundMultimodal mechanism of action of allosteric HIV-1 integrase inhibitors
Jurado, K. A., & Engelman, A. (2013) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2013.15 · Cited by 40
Self-citationSlaughter, A., Jurado, K. A., Deng, N., Feng, L., Kessl, J. J., Shkriabai, N., Larue, R. C., Fadel, H. J., Patel, P. A., Jena, N., et al. (2014) · Retrovirology · doi:10.1186/s12977-014-0100-1 · Cited by 39
“LEDGF/p75 also binds the IN tetramer through its C-terminal integrase binding domain (IBD) by inserting a small loop into a V-shaped cavity located at the HIV-1 IN CCD dimer interface [20,24-26].”
BackgroundSelf-citationAffinity switching of the LEDGF/p75 IBD interactome is governed by kinase-dependent phosphorylation
Sharma, S., Čermáková, K., Rijck, J. D., Demeulemeester, J., Fábry, M., Ashkar, S. E., Belle, S. V., Lepšík, M., Těšina, P., Duchoslav, V., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1803909115 · Cited by 43
“The solution structure of the IBD has revealed a compact right-handed bundle composed of five α-helices (27), comparable to other members of the TFIIS N-terminal domain family (TND; InterProID IPR017923) (5, 28).”
BackgroundMutations affecting interaction of integrase with TNPO3 do not prevent HIV-1 cDNA nuclear import
Cribier, A., Ségéral, E., Delelis, O., Parissi, V., Simon, A., Ruff, M., Bénarous, R., & Emiliani, S. (2011) · Retrovirology · doi:10.1186/1742-4690-8-104 · Cited by 50
Nishitsuji, H., Hayashi, T., Takahashi, T., Miyano, M., Kannagi, M., & Masuda, T. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007825 · Cited by 37
“Peptides corresponding to the residues of 154–174 (IN154–174), which contain a motif critical for the interaction with LEDGF/p75 [38,39], were used as a control.”
HIV-1 Integrase: From Biology to Chemotherapeutics
Loizidou, E. Z., Nicolaou, C. A., Nicolaides, A. V., & Kostrikis, L. G. (2007) · Current HIV Research · doi:10.2174/157016207781023965 · Cited by 43
Meehan, A. M., Saenz, D. T., Morrison, J. H., Hu, C., Peretz, M., & Poeschla, E. M. (2011) · Journal of Virology · doi:10.1128/jvi.01295-10 · Cited by 38
Inhibitors of the Interactions between HIV‐1 IN and the Cofactor LEDGF/p75
Luca, L. D., Ferro, S., Morreale, F. E., Grazia, S. D., & Chimirri, A. (2011) · ChemMedChem · doi:10.1002/cmdc.201100071 · Cited by 36
GS-9822, a Preclinical LEDGIN Candidate, Displays a Block-and-Lock Phenotype in Cell Culture
Bruggemans, A., Vansant, G., Balakrishnan, M., Mitchell, M. L., Cai, R., Christ, F., & Debyser, Z. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02328-20 · Cited by 35
“INSTIs such as dolutegravir and bictegravir are now part of preferred first-line cART cocktails (2–4). cART has been refined to once-daily regimens, and the extent of adverse effects has been greatly reduced.”
BackgroundInfluentialMultimodal Functionalities of HIV-1 Integrase
Engelman, A., & Kvaratskhelia, M. (2022) · Viruses · doi:10.3390/v14050926 · Cited by 41
“This latter interaction recapitulates the binding mode of LEDGF/p75 hotspot residue Asp366 [212,233], explaining why many ALLINIs are effective competitors of the IN-LEDGF/p75 interaction [140,209,222,226,227].”
BackgroundSelf-citationBueno, M. T. D., Garcia-Rivera, J. A., Kugelman, J. R., Morales, E., Rosas-Acosta, G., & Llano, M. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.03.063 · Cited by 39
“10, II).(13) Residues I365 and D366 in this motif, together with V408, are the main IBD residues implicated in the high-affinity interaction of LEDGF/p75 with the catalytic core domain (CCD) of HIV-1 integrase(50) (Fig.”
Background
Metadata
- Authors
- Cherepanov, P., Sun, Z.-Y. J., Rahman, S., Maertens, G., Wagner, G., & Engelman, A.
- Affiliations
- Dana-Farber Cancer Institute (US)
- Harvard University (US)
- Corresponding author
- Engelman, Alan
- Venue
- Nature Structural & Molecular Biology
- Published
- 2005-05-15
- Volume
- 12
- Issue
- 6
- Pages
- 526-532
- ISSN
- 1545-9985 (ISSN-L)
- 1545-9993
- OpenAlex
- W2083292764
- Cited by
- 235
- References
- 53
- Citations by year
- 2026: 7 · 2025: 1 · 2024: 4 · 2023: 2 · 2022: 7 · 2021: 10 · 2020: 5 · 2019: 2 · 2018: 8 · 2017: 6 · 2016: 9 · 2015: 13 · 2014: 24 · 2013: 13 · 2012: 17
- FWCI
- 5.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Structural & Molecular Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of General Medical Sciences (GM47467, P01GM047467)
- National Institute of Allergy and Infectious Diseases (AI62249, R21AI062249, AI39394, AI 37581)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Keywords
- LEDGF/p75, HIV-1 integrase, protein-protein interaction, alpha-helical bundle, interhelical loops, eIF4G, karyopherin beta, host-virus interaction, viral replication, NMR solution structure
- MeSH terms
- Amino Acid Sequence, Animals, Binding Sites, Cloning, Molecular, Fibroblast Growth Factors, Growth Substances, Humans, Mammals, Models, Molecular, Molecular Sequence Data, Magnetic Resonance Spectroscopy, Recombinant Proteins, Restriction Mapping, HIV-1, Mutagenesis, Open Reading Frames, Protein Structure, Secondary, HIV Integrase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.